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Abstract 
Aims and Method Currently, venous thromboembolism (VTE) is the third most common 
cardiovascular disease after myocardial infarction and stroke in medical and surgical patients. Less is 
known about the incidence of VTE in older people using mental health services. We aimed to 
establish the incidence of VTE on inpatient wards for older people in Tees, Esk and Wear Valleys 
NHS Foundation Trust (TEWV), but also wanted to investigate current practice in terms of 
assessment of risk of VTE and treatment given. We conducted an incidence survey of VTE on older 
people’s inpatient units in TEWV. We searched the data of inpatients discharged over a 2 year period 
from Mental Health Services for Older People in our electronic patient record system used in TEWV 
  
Results 1495 individual patient records were searched. We found 17 confirmed VTEs (12 DVT and 5 
PE) which is comparable to VTE incidence rates in general hospitals. There were no risk 
assessments done on admission and no thromboprophylaxis given. There was limited use of 
compression stockings and mobilisation.  
 
Clinical Implications The study confirmed a significant VTE incidence and the need for increased 
awareness amongst staff working in MHSOP, especially the use of thromboprophylaxis, compression 
stockings and mobilisation. This can be met by improved training of VTE awareness and 
management for clinical staff and the use of a VTE assessment tool on MHSOP inpatient units. 
Introduction 
 
The UK population is ageing: the percentage of people aged 65 and over has 
increased from 15 per cent in 1985 to 17 per cent in 2010, an increase of 1.7 million 
people. It is also projected that by 2035 those aged 65 and over will account for 23 
per cent of the total population1. With this increasing age comes a higher risk of deep 
vein thrombosis (DVT) which may in turn lead to pulmonary embolism (PE). DVT and 
PE or venous thromboembolisms (VTE) as they are collectively known, is the third 
most common cardiovascular disease after myocardial infarction and stroke in 
medical and surgical patients2. VTE incidence for general medical patients is 
approximately 2% for patients at moderate to high risk and <1% for patients at low 
risk3. 
Less is known however about the incidence of VTE in older people using mental 
health services. A clear association of VTE with antipsychotic use has been 
established4. This increased risk is low in absolute terms (4 additional cases per 
10000 exposed patients per year), but appears to be more marked among new users 
of atypical antipsychotics5. Elderly patients are among the most common recipients 
of antipsychotics and the incidence of VTE is higher in over 65s6. Underlying risk 
factors present in older psychiatric patients may further contribute to the 
aetiopathogenesis of VTE. Older psychiatric patients often present with the 
established risk factors for VTE, for example poor physical health, obesity and 
dehydration. Additionally, immobilisation due to physical restraint and 
pharmacotherapy with benzodiazepines and antipsychotics may put older people 
using mental health services at a higher risk of VTE7.  
One multicentre cross-sectional study conducted in subacute care departments, 
analogous to Mental Health Services for Older People (MHSOP) inpatient wards, 
detected DVT in 16% of patients using systematic ultrasound examination8. One 
NHS Trust providing mental health care investigated mortality and morbidity linked to 
VTE in the previous year and found 5 deaths primarily due to VTE  (2 in MHSOP, 2 
in substance misuse services and 1 in general adult MH services)9. However, 
rigorous scientific data such as randomised controlled trials for risk/benefit ratio and 
efficacy of prophylactic treatment is lacking in this patient group4. The benefit of 
thromboprophylactic treatment needs to be weighed up against the risks of adverse 
effects such as bleeding and drug interactions, especially in older people. 
As there is very little good quality evidence on the incidence of VTE in psychiatric 
inpatients, we conducted an incidence survey of VTE on inpatient units in MHSOP in 




We searched patient data from our electronic patient record system used in Tees Esk 
and Wear Valleys NHS Foundation Trust, namely Paris. Paris was first implemented 
in 2008 and all patient records are stored electronically on this system. In order to 
assess sufficient data, we searched the data of all patients discharged from MHSOP 
inpatient wards throughout TEWV over a 24 month period (July 2009 to June 2011). 
This included all discharges from MHSOP inpatient units in North Durham, South 
Durham, North Tees, South Tees and North Yorkshire during this 2 year period. In all 
we searched the data of 1495 patient discharges.  
  
The Paris system has the capacity to create a summary of an individual patient’s 
casenotes. We were therefore able to do a word search of the “Casenote Summary”, 
to search every patient’s record throughout their admission. To identify all VTEs, we 
performed our search in 2 stages.  
 
Stage 1 – To identify all confirmed VTEs and PEs, we performed keyword searches 
using: “VTE”, “DVT”, “PE”, “pulm”, “embol” and “thromb”. 
 
Stage 2 – Having identified a VTE or PE, we then recorded the following information 
for each patient with VTE:  
 
1. Age  
2. Gender  
3. Psychiatric diagnosis  
4. Whether a DVT or PE was diagnosed  
5. Treatment given  
6. Whether a VTE risk assessment was completed on admission 
7. Outcome following treatment 
8. All comorbidities  





By searching the 1495 individual patient records, we found 17 confirmed cases of 
VTE. Of the 17 cases, 12 (72%) were DVT’s and 5 (28%) PEs, so the incidence can 
be estimated as 1.14 VTE cases per patient 100 discharges. 
 
The mean age of the patients diagnosed with VTE was 78 years and patients’ ages 
ranged from 60 to 89 years. There were more females with VTEs, as would be 
expected, with the Male to Female ratio 29% to 71%. 
We found that the most common diagnosis of patients with VTE was depression, 
with vascular dementia the second most common diagnosis. 76% of patients were 
prescribed antipsychotics at the time of suffering a VTE, whilst the most commonly 
prescribed antipsychotic was olanzapine (60%). 
Examining comorbidities revealed that, apart from age, most patients did not have 
clear risk factors for VTE. However malignancy, chronic physical disease and 
immobility were present for a number of patients. 
In terms of VTE risk assessment and preventative measures (thromboprophylaxis 
and mobilisation), there were very little to be found with no record of VTE patients 
having received a VTE risk or thromboprophylaxis. Only 29% of patient’s records 
had clear evidence that mobilisation was encouraged. 
Finally, we also examined the treatment given following diagnosis of VTE and the 
outcome resulting from that. We found that patients were treated appropriately with 
Low Molecular Weight Heparin (LMWH) and warfarin, however the use of 
compression stockings were limited with only 5 of the 12 patients diagnosed with 
DVT receiving a compression stocking. In terms of outcome, 35% of patients (all 
diagnosed with PE) were transferred to an acute setting and there were no deaths 





The incidence of VTE in our survey was comparable to incidence data from acute 
trusts which emphasises the importance of increased awareness of VTE amongst 
staff working in MHSOP. Despite the significant incidence, no patients had a 
recorded VTE risk assessment on admission. This should be addressed by the use 
of a VTE assessment tool as recommended by the Department of Health. Patients 
were appropriately treated with LMWH and warfarin, but the use of compression 
stockings was more limited. There was also limited evidence of mobilisation being 
considered as part of VTE management (29%). Both of these issues could be 
addressed with better training of MHSOP clinical staff via mandatory training and e-
learning tools. In our survey the majority of the patients diagnosed with VTE were 
taking antipsychotics at the time. Although no clear conclusions can be made from 
this finding, it does emphasise the need for more conclusive evidence on the role of 
antipsychotics in the pathogenesis of VTE.  
Looking at the limitations of our study, Paris has only a limited search capacity and 
we may not have accounted for all VTE cases as not all case records may have 
been recorded on Paris. However, we feel that an underestimation of VTE incidence 
should not negate the conclusions of our survey. We did not examine critical incident 
data, so patients dying on inpatient units as a result of VTE would not be included in 
our data. Similarly, mortality data from patients who may have died after being 




1. Our survey emphasises the need for increased awareness amongst staff 
working in MHSOP of the importance of VTE risk factors, screening and 
appropriate treatment and especially the use of thromboprophylaxis, 
compression stockings and mobilisation. These issues will be addressed with 
better training of MHSOP clinical staff via mandatory training and an e-learning tool. 
2. A VTE assessment tool will be piloted on one MHSOP inpatient ward in our 
trust with a view to wider use in future in order to identify more patients who 
may benefit from thromboprophylaxis. 
3. Our survey also emphasised the need for further investigation into the link 
between antipsychotic prescribing and VTE risk. 
4. The results of this survey have been distributed to Clinical Directors and 
service managers in the trust and an action plan is being implemented. 
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